Improving the FVIII Binding Affinity of a Recombinant VWF D'D3-albumin Fusion Molecule Translates to Dosing Benefits with Respect to the Half-life Extension of Co-administered FVIII

Authors :: Eva Herzog
Michael J. Wilson
Elmar Raquet
Marcel Mischnik
Arna Andrews
Sabine Pestel
Steve K. Dower
Philipp Claar
Thomas Weimer
Source :: Science meets clinical practice.
Publication Year :: 2019
Publisher :: Georg Thieme Verlag KG, 2019.

Subjects :: Fusion
law
Chemistry
Albumin
Recombinant DNA
Half-life
Molecule
Dosing
Pharmacology
law.invention

Full Text Access

Tools